Literature DB >> 28779321

Accumulation of Chromatin Remodelling Enzyme and Histone Transcripts in Bovine Oocytes.

V Lodde1, A M Luciano1, F Franciosi1, R Labrecque2, M A Sirard3.   

Abstract

During growth, the oocyte accumulates mRNAs that will be required in the later stages of oogenesis and early embryogenesis until the activation of the embryonic genome. Each of these developmental stages is controlled by multiple regulatory mechanisms that ensure proper protein production. Thus mRNAs are stabilized, stored, recruited, polyadenylated, translated and/or degraded over a period of several days. As a consequence, understanding the biological significance of changes in the abundance of transcripts during oocyte growth and differentiation is rather complex. Nevertheless the availability of transcriptomic platforms applicable to scarce samples such as oocytes has generated large amounts of data that depict the transcriptome of oocytes under different conditions. Despite several technical constrains related to protein determination in oocytes that still limit the possibility to verify certain hypothesis, it is now possible to use mRNA levels to start building plausible scenarios. To start deciphering the changes in the level of specific mRNAs involved in chromatin remodelling, we have performed a meta-analysis of existing microarray datasets from germinal vesicle (GV) stage bovine oocytes during the final stages of oocyte differentiation. We then analysed the expression profiles of histone and histone-remodelling enzyme mRNAs and correlated these with the major histone modifications known to occur at the same period, based on data available in the literature. We believe that this approach could reveal the function of specific enzymes in the oocyte. In turn, this information will be useful in future studies, which final ambitious goal is to decipher the 'oocyte-specific histone code'.

Entities:  

Keywords:  Bovine; Chromatin configuration; Epigenetic modification; Germinal vesicle; Histone; Oocyte; Transcriptome; mRNA

Mesh:

Substances:

Year:  2017        PMID: 28779321     DOI: 10.1007/978-3-319-60855-6_11

Source DB:  PubMed          Journal:  Results Probl Cell Differ        ISSN: 0080-1844


  7 in total

1.  Recreating the Follicular Environment: A Customized Approach for In Vitro Culture of Bovine Oocytes Based on the Origin and Differentiation State.

Authors:  Alberto Maria Luciano; Rodrigo Garcia Barros; Ana Caroline Silva Soares; Jose Buratini; Valentina Lodde; Federica Franciosi
Journal:  Methods Mol Biol       Date:  2021

2.  ASAS-SSR Triennial Reproduction Symposium: The use of natural cycle's follicular dynamic to improve oocyte quality in dairy cows and heifers.

Authors:  Marc André Sirard; Françoic Xavier Grand; Remi Labrecque; Christian Vigneault; Patrick Blondin
Journal:  J Anim Sci       Date:  2018-06-29       Impact factor: 3.159

3.  A Nuclear and Cytoplasmic Characterization of Bovine Oocytes Reveals That Cysteamine Partially Rescues the Embryo Development in a Model of Low Ovarian Reserve.

Authors:  Valentina Lodde; Alberto Maria Luciano; Giulia Musmeci; Ileana Miclea; Irene Tessaro; Mariella Aru; David F Albertini; Federica Franciosi
Journal:  Animals (Basel)       Date:  2021-06-29       Impact factor: 2.752

Review 4.  Heterochromatin Morphodynamics in Late Oogenesis and Early Embryogenesis of Mammals.

Authors:  Irina Bogolyubova; Dmitry Bogolyubov
Journal:  Cells       Date:  2020-06-19       Impact factor: 6.600

5.  Folliculogenesis and acquisition of oocyte competence in cows.

Authors:  Marc-André Sirard
Journal:  Anim Reprod       Date:  2019-10-23       Impact factor: 1.807

6.  The variable success of in vitro maturation: can we do better?

Authors:  Alberto M Luciano; Federica Franciosi; Rodrigo G Barros; Cecilia Dieci; Valentina Lodde
Journal:  Anim Reprod       Date:  2018-08-03       Impact factor: 1.810

7.  Oocyte related factors impacting on embryo quality: relevance for in vitro embryo production.

Authors:  Fabienne Nuttinck
Journal:  Anim Reprod       Date:  2018-08-17       Impact factor: 1.807

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.